{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:06:51Z","timestamp":1784552811693,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004776","name":"Chulalongkorn University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CE68_032_3000_008_1"],"award-info":[{"award-number":["CE68_032_3000_008_1"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.transproceed.2026.05.017","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:18:25Z","timestamp":1781065105000},"page":"968-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients"],"prefix":"10.1016","volume":"58","author":[{"given":"Aschariya","family":"Wipattanakitcharoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kullaya","family":"Takkavatakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwasin","family":"Udomkarnjananun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paweena","family":"Susantitaphong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeerath","family":"Phannajit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0001","first-page":"1","article-title":"2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"issue":"11","key":"10.1016\/j.transproceed.2026.05.017_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrneph.2015.153","article-title":"Phosphate and FGF-23 homeostasis after kidney transplantation","volume":"11","author":"Baia","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-019-04421-5","article-title":"CKD-MBD post kidney transplantation","volume":"36","author":"Haffner","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ekir.2022.10.018","article-title":"Hyperparathyroidism is an independent risk factor for allograft dysfunction in pediatric kidney transplantation","volume":"8","author":"Prytula","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.transproceed.2026.05.017_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","article-title":"Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function","volume":"82","author":"Akaberi","year":"2006","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transproceed.2026.05.017_bib0006","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.017_bib0007","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","article-title":"Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy","volume":"163","author":"Araujo","year":"2018","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.transproceed.2019.11.020","article-title":"Risk factors and treatment options for persistent hyperparathyroidism after kidney transplantation","volume":"52","author":"Kirnap","year":"2020","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0009","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.surg.2022.07.031","article-title":"Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss","volume":"173","author":"Crepeau","year":"2023","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.017_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","article-title":"Hyperparathyroidism and long-term bone loss after renal transplantation","volume":"17","author":"Heaf","year":"2003","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2026.05.017_bib0011","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","article-title":"CKD-mineral and bone disorder management in kidney transplant recipients","volume":"61","author":"Alshayeb","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"10.1016\/j.transproceed.2026.05.017_bib0012","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/diagnostics14131358","article-title":"Persisting hypercalcemia and hyperparathyroidism after kidney transplantation have a negative impact on graft and patient survival","volume":"14","author":"Egli","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.transproceed.2026.05.017_bib0013","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1093\/oncolo\/oyad314","article-title":"Treatment of hypercalcemic hyperparathyroidism after kidney transplantation is associated with improved allograft survival","volume":"29","author":"Wang","year":"2024","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2026.05.017_bib0015","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.017_bib0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease\u2013mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.transproceed.2026.05.017_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11914-023-00782-x","article-title":"Impact of cinacalcet and etelcalcetide on bone mineral and cardiovascular disease in dialysis patients","volume":"21","author":"Bernardor","year":"2023","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.017_bib0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/0886022X.2018.1562356","article-title":"The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism","volume":"41","author":"Susantitaphong","year":"2019","journal-title":"Ren Fail"},{"issue":"26","key":"10.1016\/j.transproceed.2026.05.017_bib0019","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.transproceed.2026.05.017_bib0020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.07050714","article-title":"A randomized trial of cinacalcet versus vitamin D analogs as monotherapy in secondary hyperparathyroidism (PARADIGM)","volume":"10","author":"Wetmore","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.017_bib0021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.transproceed.2026.05.017_bib0022","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.017_bib0023","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.transproceed.2026.05.017_bib0024","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.ndt.a027843","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2026.05.017_bib0025","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1097\/01.ASN.0000144207.44469.BE","article-title":"Calcineurin Abeta is central to the expression of the renal type II Na\/Pi co-transporter gene and to the regulation of renal phosphate transport","volume":"15","author":"Moz","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.transproceed.2026.05.017_bib0026","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.017_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00126839-200809050-00004","article-title":"Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents: a randomized, open-label, crossover, single-centre study in healthy volunteers","volume":"9","author":"Padhi","year":"2008","journal-title":"Drugs R D"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.017_bib0028","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients","volume":"23","author":"Falck","year":"2008","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:55:11Z","timestamp":1784552111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0041134526002708"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}